Accuray Stock Price, News & Analysis (NASDAQ:ARAY)

Accuray trades on the NASDAQ under the ticker symbol "ARAY."

Accuray Incorporated (NASDAQ:ARAY) posted its earnings results on Thursday, August, 15th. The medical equipment provider reported ($0.02) earnings per share for the quarter, missing the Zacks' consensus estimate of $0.03 by $0.05. The medical equipment provider had revenue of $117.42 million for the quarter, compared to analysts' expectations of $116.09 million. Accuray had a negative net margin of 3.92% and a negative return on equity of 26.69%. During the same period in the previous year, the firm earned ($0.01) EPS. View Accuray's Earnings History.

Accuray is scheduled to release their next quarterly earnings announcement on Tuesday, October 29th 2019. View Earnings Estimates for Accuray.

Accuray will be holding an earnings conference call on Tuesday, October 29th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Accuray updated its FY 2020 earnings guidance on Thursday, August, 15th. The company provided EPS guidance of for the period. The company issued revenue guidance of $410-420 million, compared to the consensus revenue estimate of $436.86 million.

3 brokers have issued twelve-month price targets for Accuray's shares. Their forecasts range from $3.90 to $4.00. On average, they expect Accuray's stock price to reach $3.95 in the next twelve months. This suggests a possible upside of 45.4% from the stock's current price. View Analyst Price Targets for Accuray.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Accuray in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Accuray.

Media stories about ARAY stock have been trending somewhat positive recently, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Accuray earned a media sentiment score of 1.4 on InfoTrie's scale. They also gave news articles about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Accuray.

Accuray saw a decline in short interest in September. As of September 30th, there was short interest totalling 1,920,000 shares, a decline of 21.3% from the August 30th total of 2,440,000 shares. Based on an average trading volume of 588,200 shares, the days-to-cover ratio is presently 3.3 days. Currently, 2.2% of the shares of the company are sold short. View Accuray's Current Options Chain.

Some companies that are related to Accuray include Silk Road Medical (SILK), Luminex (LMNX), Cryolife (CRY), Shockwave Medical (SWAV), Tactile Systems Technology (TCMD), Anika Therapeutics (ANIK), Cerus (CERS), LeMaitre Vascular (LMAT), SurModics (SRDX), Axonics Modulation Technologies (AXNX), AngioDynamics (ANGO), Intersect ENT (XENT), Antares Pharma (ATRS), Orthopediatrics (KIDS) and OraSure Technologies (OSUR).

Based on aggregate information from My MarketBeat watchlists, some companies that other Accuray investors own include NVIDIA (NVDA), Activision Blizzard (ATVI), Intel (INTC), Advanced Micro Devices (AMD), Exelixis (EXEL), FireEye (FEYE), Netflix (NFLX), Tesla (TSLA), Cypress Semiconductor (CY) and iRobot (IRBT).

Shares of ARAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ARAY stock can currently be purchased for approximately $2.72.

Accuray has a market capitalization of $241.12 million and generates $418.79 million in revenue each year. The medical equipment provider earns $-16,430,000.00 in net income (profit) each year or ($0.15) on an earnings per share basis. Accuray employs 998 workers across the globe.View Additional Information About Accuray.

The official website for Accuray is http://www.accuray.com/.

Accuray's mailing address is 1310 CHESAPEAKE TERRACE, SUNNYVALE CA, 94089. The medical equipment provider can be reached via phone at 408-716-4600 or via email at [email protected]